Globe Newswire (Tue, 18-Aug 8:00 AM ET)
CareCloud Reports Second Quarter 2026 Results
Globe Newswire (Thu, 6-Aug 7:00 AM ET)
CareCloud to Announce Second Quarter 2026 Results on August 6, 2026
Globe Newswire (Thu, 16-Jul 8:00 AM ET)
Globe Newswire (Mon, 8-Jun 8:00 AM ET)
Globe Newswire (Fri, 5-Jun 8:00 AM ET)
Market Chameleon (Tue, 17-Mar 7:45 AM ET)
Market Chameleon (Thu, 12-Mar 7:06 AM ET)
CareCloud Lifts 2025 Outlook and Accelerates AI Strategy Amid Strong Profitability
Market Chameleon (Thu, 6-Nov 5:34 AM ET)
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Carecloud trades on the NASDAQ stock market under the symbol CCLD.
As of August 28, 2026, CCLD stock price declined to $2.49 with 978,354 million shares trading.
CCLD has a beta of -0.26, meaning it tends to be less sensitive to market movements. CCLD has a correlation of 0.00 to the broad based SPY ETF.
CCLD has a market cap of $105.81 million. This is considered a Micro Cap stock.
Last quarter Carecloud reported $32 million in Revenue and $.06 earnings per share. This beat revenue expectation by $9,464 and missed earnings estimates by -$.01.
In the last 3 years, CCLD traded as high as $4.84 and as low as $.68.
The top ETF exchange traded funds that CCLD belongs to (by Net Assets): VTI, AVUV, VXF, BSVO, DFAS.
CCLD has underperformed the market in the last year with a return of -32.9%, while SPY returned +20.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CCLD shares. However, CCLD has outperformed the market in the last 3 month and 2 week periods, returning +10.7% and +1.6%, while SPY returned +2.8% and -1.1%, respectively. This indicates CCLD has been having a stronger performance recently.
CCLD support price is $2.55 and resistance is $2.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCLD shares will trade within this expected range on the day.